Miranda Toledano

Miranda Toledano

Chief Executive Officer and directoratEntera Bio· In proxies 2022–2025

Pay in FY2023+40% from the year before · Entera Bio stock -17.8% the same year

Miranda Toledano was paid $950 in FY2023 (Dec), up 40%. Entera Bio stock fell 17.8% that year.

Pay$100 in the stock at the end of FY21 → $21
Pay is from the Summary Compensation Table of each Entera Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Entera BioPublic company · 4 yr
    • Chief Executive Officer and director2022 – Present · 4 yrStock in role -2%
  2. Journey MedicalPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?